nct02637284 bpc-157 status A human trial was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo-controlled clinical trial (NCT02637284) was launched BPC-157 has already hit the
Description
BPC-157 supports tissue repair while TRT provides the anabolic hormonal environment for recovery
The FDA made several important announcements that affected peptide availability

I stopped there and watched the calendar closely

I will say this, I know many MDs using these compounds and clinically are seeing very impressive outcomes
H., Tolbert D
